MSN: Study finds cost of brand-name epilepsy drugs nearly triples in eight years
UC expert says generic drugs typically are a safe, effective alternative
A new study found the cost for a year's supply of brand-name epilepsy drugs increased by 277% from 2010 to 2018, while the cost for a year's supply of generic epilepsy drugs decreased by 42% over the same time period.
Michael Privitera, MD, professor of neurology in the University of Cincinnati College of Medicine and director of the Epilepsy Center at the UC Gardner Neuroscience Institute, commented on the study for an article published by United Press International and MSN.
Privitera said he and his colleagues have performed "rigorous studies" that found no clinically important differences between generic and name-brand versions of one anti-seizure medication, lamotrigine.
The main approach to lowering prices for patients is to use generic drugs whenever possible, Privitera said, but some patients' seizures are only controlled with particular drugs that do not have generic equivalents.
Read the MSN story, originally published by United Press International.
Featured photo at top courtesy of Unsplash.
Related Stories
2024 Daniel Drake Medals to be awarded April 27
April 24, 2024
The UC College of Medicine will award three people with 2024 Daniel Drake Medals April 27.
The graduating class of 2024 shares creative works across 15...
April 24, 2024
DAAP’s Graduating Class of 2024 shares creative works across 15 interdisciplinary degree programs at DAAPworks.
Local 12: Head injury survivor, doctor share importance of...
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.